Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Canadian journal of anaesthesia = Journal canadien d'anesthesie • 2005 | View Paper
“Further, pretreatment with an intrathecal serotonin antagonist, methysergide, and an intrathecal alpha 2 adrenergic antagonist, yohimbine , abolished the antinociceptive effects of intraperitoneal ketamine in the TF and the MPP tests.”
Masui. The Japanese journal of anesthesiology • 1996 | View Paper
“Concurrent exposure to ketamine hydrochloride, xylazine, and yohimbine , an alpha 2 adrenergic receptor antagonist, resulted in corneal lesions in only 6% of rat pups so exposed.”
Investigative ophthalmology & visual science • 1988 | View Paper
“ Yohimbine , an alpha-2 adrenergic antagonist has been shown to reverse xylazine induced depression and partially antagonize ketamine in other species.”
“ Yohimbine hydrochloride has been used experimentally to reverse the anesthetic effects of ketamine and xylazine in dogs, cats, cattle and mule deer, but there are no reports of its use in nonhuman primates.”
“ Yohimbine hydrochloride (YH) effectively reversed the immobilizing effects of ketamine hydrochloride (KH) combined with xylazine hydrochloride (XH) in 48 wild polar bears (Ursus maritimus) handled in the summer.”